SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-18-000071
Filing Date
2018-06-07
Accepted
2018-06-07 16:52:28
Documents
1
Period of Report
2018-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152840473035562.html 4  
1 FORM 4 wf-form4_152840473035562.xml 4 3710
  Complete submission text file 0001600132-18-000071.txt   5205
Mailing Address C/O BELLEROPHON THERAPEUTICS 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address
Bruder Scott P (Reporting) CIK: 0001411721 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 18887051

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations